Targeting Vascular INflammation in Patients With Community-Acquired Pneumonia

Clinical trial NCT06710080 · RECRUITING

Trial details

NCT number: NCT06710080
Sponsor: Ottawa Heart Institute Research Corporation
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Inflammation Community Acquired Pneumonia (CAP)Inflammation Plaque, Atherosclerotic

Start date: 2026-04-08
Primary completion: 2026-12-31
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.